Drug delivery systems in regenerative medicine: an updated review

A Mansour, M Romani, AB Acharya, B Rahman… - Pharmaceutics, 2023 - mdpi.com
Modern drug discovery methods led to evolving new agents with significant therapeutic
potential. However, their properties, such as solubility and administration-related …

[HTML][HTML] Nanovaccines: a game changing approach in the fight against infectious diseases

MAH Abusalah, H Chopra, A Sharma… - Biomedicine & …, 2023 - Elsevier
The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …

Insights on development aspects of polymeric nanocarriers: the translation from bench to clinic

AK Tewari, SC Upadhyay, M Kumar, K Pathak… - Polymers, 2022 - mdpi.com
Scientists are focusing immense attention on polymeric nanocarriers as a prominent delivery
vehicle for several biomedical applications including diagnosis of diseases, delivery of …

Nasal vaccines: solutions for respiratory infectious diseases

R Nakahashi-Ouchida, K Fujihashi, Y Kurashima… - Trends in Molecular …, 2023 - cell.com
Nasal vaccines induce pathogen-specific dual protective immunity at mucosal surfaces and
systemically throughout the body. Consequently, nasal vaccines both prevent pathogen …

Nanovaccines to combat drug resistance: the next-generation immunisation

K Manju, SN Raj, HK Ranjini, SC Nayaka… - Future Journal of …, 2023 - Springer
Background The present review envisages the role of nanovaccines to combat the global
challenges of antimicrobial resistance. Nanovaccines are a novel formulation comprised of …

Cell-penetrating peptides for transmucosal delivery of proteins

J Wu, S Roesger, N Jones, CMJ Hu, SD Li - Journal of Controlled Release, 2024 - Elsevier
Enabling non-invasive delivery of proteins across the mucosal barriers promises improved
patient compliance and therapeutic efficacies. Cell-penetrating peptides (CPPs) are …

[HTML][HTML] Recent progress in application of nanovaccines for enhancing mucosal immune responses

G Du, M Qin, X Sun - Acta Pharmaceutica Sinica B, 2023 - Elsevier
Mucosal vaccines that stimulate both mucosal and systemic immune responses are
desirable, as they could prevent the invading pathogens at their initial infection sites in a …

Multiplex genetic manipulations in Clostridium butyricum and Clostridium sporogenes to secrete recombinant antigen proteins for oral-spore vaccination

Y Zhang, TS Bailey, P Hittmeyer, LJ Dubois… - Microbial cell …, 2024 - Springer
Background Clostridium spp. has demonstrated therapeutic potential in cancer treatment
through intravenous or intratumoral administration. This approach has expanded to include …

Acid resilience oral mucosal delivery for vaccination against Hepatitis-B

SK Saraf, RN Sahoo, S Biswal, S Mallick - Journal of Drug Delivery Science …, 2024 - Elsevier
The predominant mode of transmission for the viral infection that causes hepatitis B as the
major reason of liver cirrhosis and hepatocellular carcinoma is by the parenteral or …

A Narrative Review on the Promising Potential of Graphene in Vaccine Design: Evaluating the Benefits and Drawbacks of Carbon Nanoplates in Nanovaccine …

H Zare-Zardini, E Saberian, A Jenča, A Jenča… - Vaccines, 2024 - mdpi.com
Graphene, a two-dimensional material consisting of a single layer of carbon atoms arranged
in a honeycomb lattice, has shown great potential in various fields, including biomedicine …